DUBLIN–(BUSINESS WIRE)–The “Cell
Expansion Market by Product, Cell Type (Human, Animal), Application
(Regenerative Medicine & Stem Cell Research, Cancer & Cell-based
Research), End User, and Region – Global Forecast to 2024”
report has been added to ResearchAndMarkets.com’s
offering.
The cell expansion market is projected to reach USD 26.0 Billion by 2024
from USD 12.7 Billion in 2019, at a CAGR of 15.4% during the forecast
period.
Growth in this market is mainly driven by the increasing incidence of
chronic diseases, government investments for cell-based research, the
growing focus on personalized medicine, increasing focus on R&D for
cell-based therapies, and increasing GMP certifications for cell therapy
production facilities.
Consumables accounted for the larger share of the cell
expansion market in 2018
On the basis of products, the cell expansion market is segmented into
consumables and instruments. Consumables are segmented into reagents,
media, sera, and disposables. The instruments segment includes cell
expansion supporting equipment, bioreactors, and automated cell
expansion systems. In 2018, consumables accounted for the largest share
of the cell expansion products market owing to the constant requirement
for new reagents among end users and rising investments for R&D on
cell-based therapies.
Human cells accounted for the largest share of the cell
expansion market in 2018
Based on cell type, the cell expansion market is segmented into human
cells and animal cells. The human cells segment includes stem cells and
differentiated cells. The stem cells segment is further classified into
adult stem cells, ESCs, and iPSCs. These cells are used for therapeutic
and research purposes. In 2018, the human cells segment accounted for
the larger share of the cell expansion market majorly due to the
increasing investments by public and private organizations for research
on human cells, growing application areas of human stem cells, and the
growing incidence of diseases such as cancer.
The major players operating in this market are Thermo Fisher Scientific,
Inc. (US), Becton, Dickinson and Company (US), Terumo BCT (Japan), Merck
KGaA (Germany), Danaher Corporation (US), Miltenyi Biotec (Germany),
Lonza Group Ltd. (Switzerland), STEMCELL Technologies Inc. (Canada), GE
Healthcare (US), and Corning, Inc. (US).
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Cell Expansion Market: Market Overview
4.2 North America: Cell Expansion Market, By Product (20
4.3 Geographical Snapshot of the Cell Expansion Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Incidence of Chronic Diseases
5.2.1.2 Government Investments for Cell-Based Research
5.2.1.3 Growing Focus on Personalized Medicine
5.2.1.4 Increasing Focus on R&D for Cell-Based Therapies
5.2.1.5 Increasing GMP Certifications for Cell Therapy Production
Facilities
5.2.2 Restraints
5.2.2.1 Ethical Concerns Regarding Research in Cell Biology
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 3D Cell Expansion Technology
6 Cell Expansion Market, By Product
6.1 Introduction
6.2 Consumables
6.2.1 Media
6.2.1.1 Media Segment to Dominate the Cell Expansion Consumables Market
6.2.2 Reagents
6.2.2.1 Reagents Segment to Account for the Second-Largest Share of the
Cell Expansion Consumables Market
6.2.3 Sera
6.2.3.1 North America to Dominate the Cell Expansion Sera Market
6.2.4 Disposables
6.2.4.1 Tissue Culture Flasks
6.2.4.1.1 Tissue Culture Flasks Segment Accounted for the Largest Share
of the Disposables Market
6.2.4.2 Bioreactor Accessories
6.2.4.2.1 Bioreactor Accessories Segment Accounted for the
Second-Largest Share of the Disposables Market
6.2.4.3 Other Disposables
6.3 Instruments
6.3.1 Cell Expansion Supporting Equipment
6.3.1.1 Flow Cytometers
6.3.1.1.1 Product Launches to Drive the Growth of This Market Segment
6.3.1.2 Centrifuges
6.3.1.2.1 Major Players are Focusing on Launching New and Advanced
Centrifuges in the Market
6.3.1.3 Cell Counters & Hemocytometers
6.3.1.3.1 Technological Advancements Supporting the Growth of the Cell
Counters & Hemocytometers Market
6.3.1.4 Other Supporting Equipment
6.3.2 Bioreactors
6.3.2.1 Microcarrier Bioreactors
6.3.2.1.1 Microcarrier-Based Anchorage-Dependent Bioreactors
6.3.2.1.1.1 Microcarrier-Based Anchorage-Dependent Bioreactors Offer
Large-Scale Production
6.3.2.1.2 Suspension-Based Anchorage-Independent Bioreactors
6.3.2.1.2.1 North America is the Largest Market for Suspension-Based
Anchorage-Independent Bioreactors
6.3.2.2 Perfusion/Hollow Fiber Bioreactors
6.3.2.2.1 Collaborations and Product Launches Supporting the Growth of
This Market Segment
6.3.3 Automated Cell Expansion Systems
6.3.3.1 Technological Advancements to Drive the Growth of This Market
Segment
7 Cell Expansion Market, By Cell Type
7.1 Introduction
7.2 Human Cells
7.2.1 Stem Cells
7.2.1.1 Adult Stem Cells
7.2.1.1.1 Adult Stem Cells Segment Accounts for the Largest Share of the
Human Stem Cells Market, Primarily Due to Increased Government
Initiatives in Cell-Based Research
7.2.1.2 Induced Pluripotent Stem Cells (IPSCS
7.2.1.2.1 IPSCS are Sued in Cell Replacement Therapies, Drug Screening,
and Tissue Regeneration
7.2.1.3 Embryonic Stem Cells (ESCS
7.2.1.3.1 Increasing Private and Public Investments for Stem Cell
Research – Major Factor Driving Market Growth
7.2.2 Differentiated Cells
7.2.2.1 Increasing Prevalence of Cancer is the Major Factor Driving the
Growth of This Market
7.3 Animal Cells
7.3.1 Biopharmaceutical Companies are the Major End Users of Animal Cells
8 Cell Expansion Market, By Application
8.1 Introduction
8.2 Regenerative Medicine and Stem Cell Research
8.2.1 Increasing Government Funding on Regenerative Medicine and Stem
Cell Research to Drive Market Growth
8.3 Cancer and Cell-Based Research
8.3.1 Increasing Prevalence of Cancer to Support Market Growth
8.4 Other Applications
9 Cell Expansion Market, By End User
9.1 Introduction
9.2 Biotechnology & Biopharmaceutical Companies
9.2.1 Increasing Investments in Cell-Based Research to Drive Market
Growth
9.3 Research Institutes
9.3.1 Growth in Funding for Life Science Research to Drive the Market
for Research Institutes
9.4 Cell Banks
9.4.1 Increasing Awareness Among People About the Benefits of Preserving
Stem Cells to Drive Market Growth
9.5 Other End Users
10 Cell Expansion Market, By Region
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis, 2018
11.3 Competitive Scenario
11.3.1 Product Launches and Approvals, 2016-2019
11.3.2 Acquisitions, 2016-2019
11.3.3 Agreements, 2016-2019
11.3.4 Expansions, 2016-2019
11.4 Competitive Leadership Mapping (2018)
11.4.1 Vendor Inclusion Criteria
11.4.2 Visionary Leaders
11.4.3 Innovators
11.4.4 Dynamic Differentiators
11.4.5 Emerging Companies
12 Company Profiles
12.1 Thermo Fisher Scientific, Inc.
12.2 Becton, Dickinson and Company
12.3 Terumo BCT
12.4 Merck KGaA
12.5 Beckman Coulter Inc. (Subsidiary of Danaher Corporation
12.6 Miltenyi Biotec
12.7 Lonza Group Ltd.
12.8 Stemcell Technologies, Inc.
12.9 GE Healthcare
12.10 Corning Incorporated
For more information about this report visit https://www.researchandmarkets.com/r/uvvooj
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Biotechnology